NeuroAIDS in Brazil

J Neurovirol. 2007 Apr;13(2):89-96. doi: 10.1080/13550280601132074.

Abstract

Brazil has the largest number of HIV cases of any single country in Latin America - over 600,000. Recently, investigators have begun to characterize the extent of neurological morbidity due to HIV in this country. During 2005 and 2006, the U.S. National Institute of Mental Health cosponsored two meetings of experts aimed at summarizing existing knowledge of HIV and its neurological complications in Brazil. Topics addressed ranged from clinical neurobehavioral aspects to molecular biology. Experts attending the meeting considered fruitful directions for future research.

Publication types

  • Review

MeSH terms

  • AIDS Dementia Complex / diagnosis
  • AIDS Dementia Complex / etiology
  • AIDS Dementia Complex / pathology
  • AIDS Dementia Complex / virology
  • Acquired Immunodeficiency Syndrome / epidemiology*
  • Acquired Immunodeficiency Syndrome / etiology
  • Animals
  • Anti-Retroviral Agents / therapeutic use
  • Brain / pathology
  • Brain / virology
  • Brazil / epidemiology
  • Central Nervous System Stimulants / adverse effects
  • Cognition
  • Cognition Disorders / pathology
  • Cognition Disorders / virology
  • Comorbidity
  • Congresses as Topic
  • Developing Countries
  • Drug Resistance, Viral
  • Genetic Variation
  • Global Health
  • Government Programs
  • HIV Infections / complications
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • HIV-1* / classification
  • HIV-1* / genetics
  • Hepacivirus
  • Hepatitis C / epidemiology
  • Humans
  • Methamphetamine / adverse effects
  • Nervous System Diseases / diagnosis
  • Nervous System Diseases / drug therapy
  • Nervous System Diseases / etiology
  • Nervous System Diseases / metabolism
  • Nervous System Diseases / pathology
  • Neuropsychological Tests / standards
  • Somatostatin / metabolism

Substances

  • Anti-Retroviral Agents
  • Central Nervous System Stimulants
  • Methamphetamine
  • Somatostatin